EPHA 2018 Universal Access and Affordable Medicines Forum
ROUTES TO BETTER AND AFFORDABLE MEDICINES BY 2025
What do we want from our future medicines policy?
20 November 2018 • Scotland House, Brussels
The 2018 Universal Access and Affordable Medicines Forum comes at a critical juncture for pharmaceutical policy in Europe.
Join the Trailblazers in the European access to medicines debate on 20 November to take stock of recent unprecedented political developments and to discuss policy recommendations for the next European Commission and Member States’ priorities in terms of medicines policy.
Get updated on major political developments and their relevance for the access to medicines debate
Understand where the innovation ecosystem is headed towards
Enrich your understanding of public investment in medical R&D in Europe
Gain insight into key stakeholders’ upcoming health agendas
REGISTRATION AND COFFEE
WELCOME AND INTRODUCTION
ACCESS TO MEDICINES IN EUROPE: ARE PAYERS FACING A DEAD END?
THOUGHT LEADERS FORUM: WHERE DO WE STAND AND WHERE IS MEDICINES POLICY IN EUROPE HEADING?
PUBLIC INVESTMENT IN MEDICAL R&D IN EUROPE: WHY, WHEN, HOW & WHO?
THE INNOVATION ECOSYSTEM IN EUROPE: HOW WILL IT LOOK LIKE IN 2025?
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicine, European Public Health Alliance (EPHA)
Jo De Cock, CEO, National Institute of Health and Disability Insurance (RIZIV/INAMI), Belgium
Marjan Suselj, General Director, Health Insurance Institute of Slovenia (HIIS)
Evert Jan van Lente, Director EU-Affairs, AOK-Bundesverband, Germany
Adrian van den Hoven, Director General, Medicines For Europe
Paola Testori Coggi, Italian Medicines Agency (AIFA)
Clemens Auer, Special Envoy for Health, Federal Ministry of Labour, Social Affairs, Health and Consumer Protection, Austria
Carlo Maria Marenghi, Legal Attaché for Intellectual Property and Trade issues, Holy See
Ri De Ridder, President, Médecins du Monde, Belgium
Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations, (EFPIA)
Marie-Paule Kieny, Director of Research, French National Institute of Health and Medical Research (INSERM), France
Stefano Vella, Director, National Center for Global Health, Istituto Superiore di Sanita (ISS), Italy
Stuart Pritchard, Manager, European Union and Public Affairs, Wellcome Trust
Viviana Galli, Coordinator, European Alliance for Responsible R&D and Affordable Medicines
Rufus Pollock, Enterpreneur, Founder & President of Open Knowledge
Jan Van den Bossche, Partner, Fund+, Belgium
Zoltán Kaló, Professor of Health Economics, Eötvös Loránd University (ELTE), Hungary
Carin Uyl-de Groot, Professor of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Netherlands
Moderator: Tania Dussey-Cavassini
Policy Manager for Universal Access and Affordable Medicines